These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35781357)

  • 1. Serum free light chain analysis: persisting limitations with new kids on the block.
    Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
    Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer.
    Augustijn D; Jacobs JFM; Russcher H
    Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods.
    Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG
    Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Method Comparison and Workflow Differences Using the Same Free Light Chain Assay on 2 Analyzer Platforms.
    Omosule CL; Hock KG; Dalton C; Scalpati A; Gronowski AM; Brants A; Farnsworth CW
    J Appl Lab Med; 2023 Jul; 8(4):689-699. PubMed ID: 37186660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains.
    Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV
    Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the new Sebia free light chain assay using the AP22 ELITE instrument.
    Lutteri L; Aldenhoff MC; Cavalier E
    Clin Chim Acta; 2018 Dec; 487():161-167. PubMed ID: 30243748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verification of Newly FDA-Approved Kappa and Lambda Free Light Chain Assays on a Previously Untested Platform.
    Muluhngwi P; Sharp CN; Pozzi N; Elin RJ; Jortani SA
    J Appl Lab Med; 2019 Nov; 4(3):323-330. PubMed ID: 31659070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
    Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
    Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents.
    Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D
    Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of serum-free light-chain levels with markers of renal function.
    Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
    Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2 Serum Free Light Chain Assays with Creatinine Normal and Abnormal Populations Demonstrates the Need for Standardization.
    Griffiths M; Cheng PL; Wang XY; Schneider R; Kulasingam V
    J Appl Lab Med; 2024 Sep; 9(5):978-988. PubMed ID: 38973026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay.
    Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA
    Pathology; 2015 Oct; 47(6):564-9. PubMed ID: 26352111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy.
    Treger RS; Mathias PC; Cowan AJ; Green D; Hutchinson K; Bryan A; Chaudhary A; Fink SL; Wener MH; Morishima C
    Am J Clin Pathol; 2024 Mar; 161(3):216-231. PubMed ID: 37936261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers.
    Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB
    Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring.
    Singh G; Whitaker BM; Wu AHB; Xu H; Bollag RJ
    J Appl Lab Med; 2022 Oct; 7(6):1290-1301. PubMed ID: 36006797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool.
    Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT
    Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
    Morales-García LJ; Pacheco-Delgado MS
    Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Free Light Chain Assay: Shift Toward a Higher κ/λ Ratio.
    Rindlisbacher B; Schild C; Egger F; Bacher VU; Pabst T; Leichtle A; Andres M; Sédille-Mostafaie N
    J Appl Lab Med; 2020 Jan; 5(1):114-125. PubMed ID: 32445339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the N-latex serum free light chain assay on the Siemens BNII analyzer and agreement with The Binding Site FreeLite assay on the SPA
    White-Al Habeeb NMA; Earle T; Spencer M; Blasutig IM
    Clin Biochem; 2018 Jan; 51():90-96. PubMed ID: 28512013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Freelite and Kloneus assays in free light chain measurements in patients with renal impairment.
    Morales-García LJ; Lillo Rodríguez RM; Pacheco-Delgado MS
    Clin Biochem; 2023 Aug; 118():110610. PubMed ID: 37429509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.